Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

Taisuke Imamura(The University of Texas MD Anderson Cancer Center), Eigo Otsuji(Kyoto Prefectural University of Medicine)
Scientific Reports
July 12, 2017
Cited by 58


Related Papers